Sheila Walcoff has left the law firm McDermott Will & Emery, where she served as a partner in the Health Law Department and Life Sciences Government Strategies Practice Group. She is now founding principal at Goldbug Strategies, a strategic consulting firm focused on genomics and personalized medicine, FDA regulatory and medical product reimbursement policies, CLIA requirements, and legislative strategy and advocacy for medical products.
Walcoff was also a member of the now-disbanded HHS Secretary's Advisory Committee on Genetics, Health, and Society.
Caris Life Sciences has named Amy Jensen Cunniffe as senior vice president for government affairs. She will be responsible for Caris’ public policy and government relations efforts and will be based in Washington, DC.
Cunniffe previously led GE Healthcare's government relations team, and was a director at the lobbying firm Quinn, Gillespie and Associates. She also was a special assistant to the president for legislative affairs, a liaison between Congress and the White House.
Foundation Medicine has tapped Gary Palmer for the newly created position of senior vice president of medical affairs and commercial development.
Palmer joins the firm from On-Q-ity, where he was chief medical officer and head of development for DNA repair marker development and circulating tumor cell technology. He also served as vice president of medical affairs at Genomic Health, where he helped the company commercialize the Oncotype DX breast cancer assay. Prior to that, he worked at Amgen.
Palmer also served as director of the Medical Breast Service at University of California Davis Cancer Center and chief of medical oncology at Mercy Health System.
He holds a BA from Yale University; a PhD from the Stanford University School of Medicine; an MBA from UC Davis; an MPH from the University of California, Los Angeles; and a law degree from Concord University.